Revascularisation or medical therapy in elderly patients with acute anginal syndromes: the RINCAL randomised trial
Adam de Belder, David Hildick‐Smith(Sussex County Community College), William Smith(Nottingham University Hospitals NHS Trust), Fraser Witherow(Dorset County Hospital NHS Foundation Trust), Aung Myat(Royal Sussex County Hospital), Jonathan Byrne(Emory University), Peter Haworth(Imperial College Healthcare NHS Trust), Peter O’Kane(Royal Bournemouth Hospital), Robert Gerber(East Sussex Healthcare NHS Trust), Robert Hatrick(Worthing Hospital), Osama Alsanjari, Juliet Wright(Brighton and Sussex Medical School), Rajesh Aggarwal(Southend University Hospital NHS Foundation Trust), Andrew Davie(Golden Jubilee National Hospital), Derek Robinson(East Sussex County Council), Jonathan Blaxill, Dawn Adamson(St Thomas' Hospital)
Cited by 67
Related Papers
Percutaneous coronary intervention in stable angina (ORBITA): a double-blind, randomised controlled trial
|The Lancet|2017|1k
Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism
|New England Journal of Medicine|2013|918
Transcatheter Aortic Valve Replacement for Degenerative Bioprosthetic Surgical Valves
|Circulation|2012|580
Dual Antiplatelet Therapy after PCI in Patients at High Bleeding Risk
|New England Journal of Medicine|2021|571
Percutaneous Revascularization for Ischemic Left Ventricular Dysfunction
|New England Journal of Medicine|2022|566